10QSB 1 e-6246.txt QUARTERLY REPORT FOR THE QTR ENDED 12/31/00 ================================================================================ U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ----------------- FORM 10-QSB [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2000 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ____________ Commission File Number 000-27548 ----------------- LIGHTPATH TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) DELAWARE 86-0708398 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) http://www.lightpath.com 3819 Osuna, N.E. 87109 Albuquerque, New Mexico (Zip Code) (Address of principal executive offices) Registrant's telephone number, including area code: (505)342-1100 ----------------- Check whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES [X] NO [ ] Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practical date: Common Stock, Class A, $.01 par value 19,321,487 shares Class Outstanding At January 31, 2001 ================================================================================ LIGHTPATH TECHNOLOGIES, INC. FORM 10-QSB INDEX ITEM PAGE ---- ---- PART I FINANCIAL INFORMATION Consolidated Balance Sheets 2 Consolidated Statements of Operations 3 Consolidated Statements of Cash Flows 4 Notes to Consolidated Financial Statements 5 Management's Discussion and Analysis of Financial Condition and Results of Operations 12 PART II OTHER INFORMATION Legal Proceedings 18 Changes in Securities and Use of Proceeds 18 Defaults Upon Senior Securities 18 Submission of Matters to a Vote of Security Holders 19 Other Information 19 Exhibits and Reports on Form 8-K 19 SIGNATURES 20 LIGHTPATH TECHNOLOGIES, INC. CONSOLIDATED BALANCE SHEETS (UNAUDITED)
DECEMBER 31, JUNE 30, 2000 2000 ------------- ------------- ASSETS Current assets: Cash and cash equivalents $ 38,247,078 $ 58,728,130 Trade accounts receivable - less allowance of $105,528 and $15,000 5,238,150 841,533 Inventories (NOTE 2) 4,479,812 1,690,058 Advances to employees and related parties 29,747 17,733 Prepaid expenses and other 452,673 225,451 ------------- ------------- Total current assets 48,447,460 61,502,905 Property and equipment - net 10,757,909 6,482,039 Goodwill and intangible assets - net (NOTES 3 AND 4) 46,349,597 31,727,811 Investment in LightChip, Inc. (NOTE 5) 8,234,885 1,000,000 ------------- ------------- Total assets $ 113,789,851 $ 100,712,755 ============= ============= LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 1,108,532 $ 1,573,531 Accrued liabilities 548,208 469,771 Accrued payroll and benefits 992,203 330,734 Current portion of long-term debt and capital lease obligations 357,379 -- ------------- ------------- Total current liabilities 3,006,322 2,374,036 Long-term debt and capital lease obligations 572,239 -- Deferred income taxes 3,316,304 -- Commitments and contingencies Redeemable common stock (NOTE 6) Class E-1, E-2 and E-3 - performance based and redeemable common stock; 0 and 4,022,037 shares issued and outstanding -- 40,221 Stockholders' equity (NOTE 6) Preferred stock: $.01 par value; 5,000,000 shares authorized; Series F convertible shares; 127 and 153 shares issued and outstanding, $1,270,000 liquidation preference at December 31, 2000 1 1 Common stock: Class A, $.01 par value, voting; 34,500,000 shares authorized; 19,273,968 and 18,136,254 shares issued and outstanding 192,740 181,363 Additional paid-in capital 176,974,118 142,559,848 Accumulated deficit (70,271,873) (44,442,714) ------------- ------------- Total stockholders' equity 106,894,986 98,298,498 ------------- ------------- Total liabilities and stockholders' equity $ 113,789,851 $ 100,712,755 ============= =============
SEE ACCOMPANYING NOTES 2 LIGHTPATH TECHNOLOGIES, INC. CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
THREE MONTHS ENDED SIX MONTHS ENDED DECEMBER 31, DECEMBER 31, ----------------------------- ----------------------------- 2000 1999 2000 1999 ------------ ------------ ------------ ------------ REVENUES Telecom product and lens sales $ 7,757,106 $ 215,295 $ 10,654,675 $ 379,477 Product development fees and other sales 3,500 62,500 170,870 167,423 ------------ ------------ ------------ ------------ Total revenues 7,760,606 277,795 10,825,545 546,900 COSTS AND EXPENSES Cost of sales 4,711,487 105,009 6,436,261 189,830 Selling, general and administrative 4,275,338 979,716 7,683,828 1,647,065 Research and development 1,768,900 189,169 3,131,243 290,265 Stock-based compensation 2,782,773 -- 5,482,773 -- Amortization of goodwill and intangibles 3,676,212 5,531 6,214,342 10,781 Acquired in process research and development -- -- 9,100,000 -- ------------ ------------ ------------ ------------ Total costs and expenses 17,214,710 1,279,425 38,048,447 2,137,941 ------------ ------------ ------------ ------------ Operating loss (9,454,104) (1,001,630) (27,222,902) (1,591,041) OTHER INCOME(EXPENSE) Investment income 646,873 45,448 1,487,930 54,660 Interest and other expense (37,730) (397) (48,722) (436,576) ------------ ------------ ------------ ------------ Net loss $ (8,844,961) $ (956,579) $(25,783,694) $ (1,972,957) Imputed dividend and premium on preferred stock (18,551) (1,183,042) (45,464) (1,191,200) ------------ ------------ ------------ ------------ Net loss applicable to common shareholders (NOTE 7) $ (8,863,512) $ (2,139,621) $(25,829,158) $ (3,164,157) ============ ============ ============ ============ Basic and diluted net loss per share (NOTE 7) $ (.46) $ (.32) $ (1.38) $ (.53) ============ ============ ============ ============ Number of shares used in per share calculation 19,242,857 6,786,966 18,785,241 6,004,947 ============ ============ ============ ============
SEE ACCOMPANYING NOTES. 3 LIGHTPATH TECHNOLOGIES, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
SIX MONTHS ENDED DECEMBER 31, ---------------------------------- 2000 1999 ------------ ------------ CASH FLOWS FROM OPERATING ACTIVITIES Net loss $(25,783,694) $ (1,972,957) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization 7,343,661 212,125 Write-off of abandoned patent applications -- 33,764 Debt discount -- 425,795 Stock-based compensation 5,482,773 -- Acquired in-process research and development 9,100,000 -- Changes in operating assets and liabilities (net of the effect of the acquisition of Geltech, Inc.): Receivables and advances to employees (3,192,176) 66,416 Inventories (1,721,669) (68,370) Prepaid expenses and other (153,655) (13,315) Accounts payable and accrued expenses (647,184) 52,109 ------------ ------------ Net cash used in operating activities (9,571,944) (1,264,433) CASH FLOWS FROM INVESTING ACTIVITIES Property and equipment additions, net (3,968,052) (419,697) Costs incurred in acquiring patents and license agreements (33,550) (46,843) Acquisition of Geltech, Inc., net of cash acquired (18,411) -- Investment in LightChip (7,234,885) (1,570,000) ------------ ------------ Net cash used in investing activities (11,254,898) (2,036,540) CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from issuance of 6% convertible debentures, net of discount and offering costs -- 893,326 Payments on note payable and capital leases (797,561) (30,000) Proceeds from sales of Convertible Series F preferred stock, net -- 3,880,496 Proceeds from exercise of common stock options and warrants, net 1,143,351 3,569,243 Proceeds from issuance of common stock -- 258,800 ------------ ------------ Net cash provided by financing activities 345,790 8,571,865 ------------ ------------ Net (decrease) increase in cash and cash equivalents (20,481,052) 5,270,892 Cash and cash equivalents at beginning of period 58,728,130 413,388 ------------ ------------ Cash and cash equivalents at end of period $ 38,247,078 $ 5,684,280 ============ ============ SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Class A common stock, warrant and stock options issued to acquire Geltech, Inc. $ 27,713,837 $ -- Class A common stock issued upon conversion of preferred stock $ 556 $ 5,450 Class E common stock issued $ -- $ 363 Class E common stock redemption $ 40,221 $ --
SEE ACCOMPANYING NOTES 4 LIGHTPATH TECHNOLOGIES, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED DECEMBER 31, 2000 ORGANIZATION LightPath Technologies, Inc. ("LightPath" or the "Company") was incorporated in Delaware on June 15, 1992 as the successor to LightPath Technologies Limited Partnership formed in 1989, and its predecessor, Integrated Solar Technologies Corporation formed in 1985. On April 14, 2000, the Company acquired Horizon Photonics, Inc. ("Horizon"). On September 20, 2000, the Company acquired Geltech, Inc. ("Geltech"). The Company is engaged in the production of collimator, isolator, and precision molded aspherical optics used in the telecom components market, GRADIUM(R) glass lenses and other optical materials. Additionally, Geltech has a unique and proprietary line of all-glass diffraction gratings (StableSil(R)) for telecom applications as well as a product family of Sol-Gel based waveguides. The Company also performs research and development for optical solutions for the fiber telecommunications and traditional optics markets. As used herein, the terms ("LightPath" or the "Company"), refer to LightPath individually or, as the context requires, collectively with its subsidiaries on a consolidated basis. BASIS OF PRESENTATION The accompanying unaudited financial statements have been prepared in accordance with the instructions to Item 310(b) of Regulation S-B and, therefore, do not include all information and footnotes necessary for a fair presentation of financial position, results of operations, and cash flows in conformity with generally accepted accounting principles. These consolidated financial statements should be read in conjunction with the Company's consolidated financial statements and related notes included in its Form 10-KSB for the fiscal year ended June 30, 2000, as filed with the Securities and Exchange Commission on August 31, 2000. 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The accounting policies as set forth in LightPath's Annual Report on Form 10-KSB for the fiscal year ended June 30, 2000, have been adhered to in preparing the accompanying interim consolidated financial statements. These statements are unaudited but include all adjustments, which include normal recurring adjustments, that the Company considers necessary to present fairly the financial position, results of operations and cash flows of the Company for the interim periods presented. Results of operations for interim periods are not necessarily indicative of results which may be expected for the year as a whole. Revenues from two customers of the Company's telecom segment represent approximately $5.7 million or 53% of the Company's consolidated revenues for the six month period ended December 31, 2000. Effective July 1, 2000, the Company adopted Statement of Financial Accounting Standards ("SFAS") 133, "Accounting for Derivative Instruments and Hedging Activities", as amended by SFAS 138. SFAS 133, as amended, establishes accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts and for hedging activities. The Company did not have any outstanding derivatives at December 31, 2000 or July 1, 2000, and as such, adoption of SFAS 133 had no impact on the Company's financial position or results of operations for the three or six month periods ended December 31, 2000. 5 LIGHTPATH TECHNOLOGIES, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED 2. INVENTORIES The components of inventories include the following at: DECEMBER 31 JUNE 30 2000 2000 ---------- ---------- Raw materials $2,530,613 $ 733,050 Work in process 589,217 459,789 Finished goods 1,359,982 497,219 ---------- ---------- Total inventories $4,479,812 $1,690,058 ========== ========== 3. INTANGIBLE ASSETS Intangible assets consist of the following at: DECEMBER 31 JUNE 30 2000 2000 ----------- ----------- Goodwill $11,797,725 $11,797,725 Customer list 18,600,000 15,900,000 Developed technology 18,000,000 2,400,000 Covenant not-to-compete 3,100,000 2,000,000 Other intangibles 2,860,000 1,520,000 Patents and trademarks granted 620,563 509,095 License agreements 40,323 40,000 Patent applications in process 45,181 60,845 ----------- ----------- 55,063,792 34,227,665 Less accumulated amortization 8,714,195 2,499,854 ----------- ----------- Total intangible assets $46,349,597 $31,727,811 =========== =========== 4. ACQUISITIONS On September 20, 2000, the Company acquired all of the outstanding shares of Geltech, for an aggregate purchase price of approximately $28.5 million, comprised of 822,737 shares of Class A common stock (valued at $27.5 million) and approximately $1 million in acquistion costs. The number of shares of Class A common stock issued to the former shareholders of Geltech was based on the average closing price of the Class A common stock for five days prior to the date of the purchase agreement, August 9, 2000. Geltech, a Delaware corporation, is a leading manufacturer of precision molded aspherical optics used in the active telecom components market to provide a highly efficient means to couple laser diodes to fibers or waveguides. Additionally, Geltech has a unique and proprietary line of all-glass diffraction gratings (StableSil(R)) for telecom applications such as optical switching, mux/demux and laser tuning as well as a product family of Sol-Gel based waveguides. The acquisition has been accounted for using the purchase method of accounting and, accordingly, the results of operations of Geltech have been included in the Company's consolidated financial statements from September 20, 2000. The purchase price was allocated to the tangible net assets and identifiable intangible assets. The value of the tangible net assets acquired approximated their historical book value at the date of the acquisition excluding previously acquired goodwill and certain licensed technology at the acquisition date. In addition, a deferred tax liability of approximately $8.3 million was recorded together with a reduction in the Company's deferred tax valuation allowance of approximately $5 million at the acquisition date. The estimated fair value of the tangible net assets and identifiable intangible assets, based on management's assessment, are as follows: 6 LIGHTPATH TECHNOLOGIES, INC. LIGHTPATH TECHNOLOGIES, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED FAIR VALUE AT ACQUISITION -------------- Current assets $ 3,127,107 Equipment 1,437,138 Patents 62,577 In-process research and development 9,100,000 Customer list 2,700,000 Developed technology 15,600,000 Covenants not-to-compete 1,100,000 Patents, trademark & tradename 600,000 Acquired work force 740,000 Current liabilities (922,091) Long-term debt and capital leases (1,727,179) Deferred income taxes (3,316,304) ------------ Total $ 28,501,248 ============ In the first quarter of fiscal 2000, the Company recorded an immediate non-recurring charge of $9.1 million, due to acquired in-process research and development based on an assessment of purchased technology of Geltech. This charge represents technology that did not meet the accounting definitions of "completed technology," and thus should be charged to earnings under generally accepted accounting principles. This assessment analyzed certain diffractive gratings, waveguides, lens arrays and sub-assembly technologies that were under development at the time of acquisition. These programs were in various stages of completion ranging from 30% to 50% of completion, with estimated completion dates through December 2001. This in-process research will have no alternative future uses if the products are not feasible. Revenues from in-process products are estimated primarily beginning in fiscal 2002, with projected research and development costs-to-complete of approximately $2.25 million. The estimated fair value of these development programs was determined in accordance with views expressed by the staff of the Securities and Exchange Commission. On April 14, 2000, the Company acquired Horizon Photonics, Inc. ("Horizon") a California corporation, which is an emerging leader in the automated production of passive optical components for the telecommunications and data communications markets. LightPath acquired all of the outstanding shares of Horizon for approximately 1.4 million shares of Class A common stock and $1 million cash, for a total purchase price of approximately $36.2 million. The acquisition has been accounted for using the purchase method of accounting and, accordingly, the results of operations of Horizon have been included in the Company's consolidated financial statements from April 14, 2000. In the fourth quarter of fiscal 2000, the Company recorded an immediate non-recurring charge of $4.2 million, due to acquired in-process research and development based on an assessment of purchased technology of Horizon. The following unaudited pro forma information presents the results of operations of the Company as if the acquisition of Horizon and Geltech had taken place at the beginning of fiscal 2000 and excludes the write-off of the acquired in-process research and development of $4.2 million and $9.1 million, respectively. (IN 000'S EXCEPT PER SHARE DATA) DECEMBER 31, 2000 DECEMBER 31, 1999 -------------------------------- ----------------- ----------------- Revenues $ 13,310 $ 4,543 Net loss applicable to common shareholders $(19,166) $(11,289) Net loss per basic and diluted share $ (1.00) $ (1.36) 7 LIGHTPATH TECHNOLOGIES, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED The pro forma information is presented for informational purposes only and is not necessarily indicative of the results of operations that actually would have been achieved had the acquisitions been consummated as of that date, nor is it intended to be a projection of future results. 5. INVESTMENT IN LIGHTCHIP, INC. In August 2000, LightChip, Inc. issued to investors additional shares of voting convertible preferred stock for $60 million, of which the Company purchased $7.2 million. The Company's combined common stock and preferred stock voting interest in LightChip decreased from approximately 18% to 16.6% after the August 2000 investment. 6. STOCKHOLDERS' EQUITY The Company's authorized common stock includes, 2,000,000 shares of Class E-1 common stock, 2,000,000 shares of Class E-2 common stock and 1,500,000 shares of Class E-3 common stock (collectively the "E Shares" ) with $.01 par value. The stockholders of E Shares are entitled to one vote for each share held. Each E Share was automatically convertible into one share of Class A common stock in the event that the Company's income before provision of income taxes and extraordinary items or any charges which result from the conversion of the E Shares was equal to or in excess of a minimum value of approximately $13.5 million in fiscal 2000. Since the conversion provisions expired without being met as of June 30, 2000, the E Shares were redeemed by the Company, effective as of September 30, 2000. The holders of E Shares will receive their redemption value of $.0001 per share upon resolution of certain stockholder litigation relating to E Shares. See Note 9. The Series F Convertible Preferred Stock have a stated value and liquidation preference of $10,000 per share, plus an 7% per annum premium. The holders of the Series F Convertible Preferred Stock are not entitled to vote or to receive dividends. Each share of Series F Convertible Preferred Stock is convertible at the option of the holder, into Class A common stock based on its stated value at the conversion date divided by a conversion price. The conversion price is defined as the lesser of $5.00 or 80% of the average closing bid price of the Company's Class A common stock for the five days preceding the conversion date. The Company accounted for the beneficial conversion feature associated with the Series F Convertible Preferred Stock at issuance. There were 55,704 shares of Class A common stock issued upon the conversion of 26 shares of Series F Preferred Stock during the six months ended December 31, 2000.
WARRANTS PREFERRED COMMON CLASS COMMON UNIT STOCK STOCK C, E, L STOCK PURCHASE SHARES OUTSTANDING SERIES F CLASS A & OTHER OPTIONS OPTIONS ------------------ -------- ------- ------- ------- ------- Outstanding at June 30, 2000 153 18,136,254 339,547 3,199,526 2,145 Conversions (26) 64,288 -- -- (2,145) Option grants -- -- -- 532,213 -- Exercise of options and warrants -- 250,689 (47,000) (209,374) -- Forfeitures -- -- -- (9,058) -- Acquisition of Geltech -- 822,737 6,753 -- -- ---- ---------- -------- ---------- ------- Outstanding at December 31, 2000 127 19,273,968 299,300 3,513,307 -- ==== ========== ======== ========== =======
8 LIGHTPATH TECHNOLOGIES, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED 7. NET LOSS PER SHARE Basic net loss per common share is computed based upon the weighted average number of shares of Class A common stock outstanding during each period presented. The computation of Diluted net loss per common share does not differ from the basic computation because potentially issuable securities would be anti-dilutive. The following outstanding securities were not included in the computation of diluted earnings per share at December 31, 2000: 3,513,307 shares of Class A common stock issuable upon exercise of outstanding stock options, 299,300 shares of Class A common stock issuable upon exercise of private placement and other warrants, 307,340 shares of Class A common stock issuable upon the conversion of convertible preferred stock (minimum of 274,703 shares based on the fixed conversion price at closing). A seven percent premium earned by the preferred shareholders of $18,551 and $46,522 increased the net loss applicable to common shareholders for the three months ended December 31, 2000 and 1999, respectively. A seven percent premium earned by the preferred shareholders of $45,464 and $54,680 increased the net loss applicable to common shareholders for the six months ended December 31, 2000 and 1999, respectively. In addition, net loss applicable to common shareholders was increased by an imputed dividend in the amount of $1,136,520 for the three months and six months ended December 31, 1999. The imputed dividend resulted from a beneficial conversion feature associated with the Series F Preferred Stock issued on November 2, 1999. 9 LIGHTPATH TECHNOLOGIES, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED 8. SEGMENT INFORMATION Optoelectronics and Fiber Telecommunications (optoelectronics), which represents 80% of total revenues of the Company, and Traditional Optics, which represents 20% of total revenues, are the Company's reportable segments under SFAS No. 131, Disclosure about Segments of an Enterprise and Related Information (SFAS 131). The optoelectronics segment is based primarily on the development and sale of fiber collimators and fiber-optic switches, free space isolators, precision molded aspherical optics and other related passive component products for the optoelectronics segment of the telecommunications industry. The traditional optics segment is based primarily upon the sale of lenses to the data storage and medical equipment market and the development and sale of GRADIUM glass in the form of lenses and blanks for the general optics markets. Summarized financial information concerning the Company's reportable segments for the six months and three months ended December 31, is shown in the following table. Geltech's sales since September 20, 2000 are included in the fiscal 2001 results.
SEGMENT OPTO- TRADITIONAL CORPORATE INFORMATION ELECTRONICS OPTICS AND OTHER (1) TOTAL ----------- ----------- ------ ------------- ----- SIX MONTHS ENDED DECEMBER 31 Revenues (2) 2000 $ 8,643,480 2,182,065 -- $ 10,825,545 1999 84,927 461,973 -- 546,900 Segment operating loss (3) 2000 $ (3,429,433) (41,966) (23,751,503) $(27,222,902) 1999 (584,292) (195,992) (810,757) (1,591,041) ------------ ---------- ------------ ------------ THREE MONTHS ENDED DECEMBER31 Revenues (2) 2000 $ 5,828,224 1,932,382 -- $ 7,760,606 1999 52,363 225,432 -- 277,795 Segment operating loss (3) 2000 $ (1,604,472) (275,081) (8,124,713) $ (9,454,104) 1999 (347,120) (168,640) (485,870) (1,001,630) ------------ ---------- ------------ ------------
(1) Corporate functions include certain members of executive management, the corporate accounting and finance function, non-cash charges and other typical administrative functions which are not allocated to segments. (2) There were no inter-segment sales during all periods presented. (3) In addition to unallocated corporate functions, management does not allocate interest expense, interest income, and other non-operating income and expense amounts in the determination of the operating performance of the reportable segments. 10 LIGHTPATH TECHNOLOGIES, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED 9. CONTINGENCIES On May 2, 2000, the Company commenced a class action lawsuit in the Chancery Court of Delaware, New Castle County. The action seeks a declaratory judgment with respect to the Company's right to redeem the Class E Common Stock on December 31, 2000 for $.0001 per share, the right of the holders of Class E Common Stock to vote at the Annual Meeting to be held on October 6, 2000, and for certification of the holders of Class E Common Stock as a class and the named defendants as its representatives. The named defendants are Donald E. Lawson, President, Chief Executive Officer and a Director of the Company, who owns an aggregate of 25,000 shares of Class E Common Stock, Louis G. Leeburg, a Director of the Company, who owns an aggregate of 7,272 shares of Class E Common Stock, and William Leeburg, who owns or controls an aggregate of 21,816 shares of Class E Common Stock. The Company entered into a proposed settlement of this lawsuit whereby the holders of Class E Common Stock could elect to receive $.40 for each share of Class E Common Stock or a two year option to purchase one Class A Common Stock for each 100 shares of Class E Common Stock they hold. The option would be priced at the fair market value of the Class A Common Stock on the settlement date. The Company estimates that if all of the Class E Common Stock were exchanged for options to purchase Class A Common Stock, approximately 40,221 shares of Class A Common Stock would be issued. If all of the Class E Common Stock were exchanged for cash, approximately $1.6 million would be expended. On January 8, 2001, the Delaware Chancery Court held a hearing on the proposed settlement. The settlement proposal was made to include all holders of Class E Common Stock holders. On February 2, 2001, the Delaware Chancery Court issued a letter in which it indicated that holders of Class E Common Stock must be provided an opportunity to request exclusion from the settlement class. In light of the Chancery Court's letter, the Company is evaluating the proposed settlement offer and exploring various other strategies for resolving the Delaware lawsuit. Due to the uncertainty regarding the proposed settlement offer, the different exchange methods and the coverage of insurance for such claims, the Company has not been able to determine that it is probable that the settlement offer above will occur nor the likely amounts to be accrued for any possible settlement costs. On or about June 9, 2000, a small group of holders of Class E Common Stock commenced an action in a state court in Texas (the "Texas Action"). In essence, the Texas Action makes various allegations regarding the circumstances surrounding the issuance of the Class E Common Stock and seeks damages based upon those allegations. The Company believes the allegations underlying the Texas Action have no basis in fact and that this lawsuit is without merit. The Company has retained counsel and intends to vigorously defend against these claims. On November 15, 2000, the Company filed a complaint against Carmichael & Company LLC, in the State of New Mexico, for violation of its agreement with the Company as financial advisors and seeking to terminate the agreement. On or about November 15, 2000, Carmichael & Company LLC filed a complaint against the Company in the State of New York, for breach of contract and claiming approximately $5 million in damages. The Company believes the allegations underlying the New York claims have no basis in fact and that this lawsuit is without merit. The Company has retained counsel and intends to vigorously defend against these claims. LightPath is subject to various other claims and lawsuits in the ordinary course of its business, none of which are considered material to the Company's financial condition and results of operations. Except as set forth above, there have been no material developments in any legal actions reported in the Company's Form 10-KSB for the year ended June 30, 2000. 11 LIGHTPATH TECHNOLOGIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES A SAFE HARBOR FOR FORWARD LOOKING STATEMENTS MADE BY OR ON BEHALF OF THE COMPANY. ALL STATEMENTS IN THIS "MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS" AND ELSEWHERE IN THIS REPORT, OTHER THAN STATEMENTS OF HISTORICAL FACTS, WHICH ADDRESS ACTIVITIES, EVENTS OR DEVELOPMENTS THAT THE COMPANY EXPECTS OR ANTICIPATES WILL OR MAY OCCUR IN THE FUTURE, INCLUDING SUCH THINGS AS FUTURE CAPITAL EXPENDITURES, GROWTH, PRODUCT DEVELOPMENT, SALES, BUSINESS STRATEGY AND OTHER SIMILAR MATTERS ARE FORWARD-LOOKING STATEMENTS. THESE FORWARD-LOOKING STATEMENTS ARE BASED LARGELY ON THE COMPANY'S CURRENT EXPECTATIONS AND ASSUMPTIONS AND ARE SUBJECT TO A NUMBER OF RISKS AND UNCERTAINTIES, MANY OF WHICH ARE BEYOND THE COMPANY'S CONTROL. ACTUAL RESULTS COULD DIFFER MATERIALLY FROM THE FORWARD-LOOKING STATEMENTS SET FORTH HEREIN AS A RESULT OF A NUMBER OF FACTORS, INCLUDING, BUT NOT LIMITED TO, THE COMPANY'S EARLY STAGE OF DEVELOPMENT, THE NEED FOR ADDITIONAL FINANCING, INTENSE COMPETITION IN VARIOUS ASPECTS OF ITS BUSINESS AND OTHER RISKS DESCRIBED IN THE COMPANY'S REPORTS ON FILE WITH THE SECURITIES AND EXCHANGE COMMISSION. IN LIGHT OF THESE RISKS AND UNCERTAINTIES, ALL OF THE FORWARD-LOOKING STATEMENTS MADE HEREIN ARE QUALIFIED BY THESE CAUTIONARY STATEMENTS AND THERE CAN BE NO ASSURANCE THAT THE ACTUAL RESULTS OR DEVELOPMENTS ANTICIPATED BY THE COMPANY WILL BE REALIZED. THE COMPANY UNDERTAKES NO OBLIGATION TO UPDATE OR REVISE ANY OF THE FORWARD LOOKING STATEMENTS CONTAINED HEREIN. RESULTS OF OPERATIONS THREE MONTHS ENDED DECEMBER 31, 2000 COMPARED WITH THE THREE MONTHS ENDED DECEMBER 31, 1999 TELECOM SEGMENT For the second quarter of fiscal 2001 telecom product sales increased 107% to approximately $5.8 million versus $2.8 million for the first quarter of fiscal 2001 and $52,363 for the comparable period last year. The telecom segment results include $1.4 million of collimator product sales, isolator sales of $3.1 and $1.3 million of active telecom components sales. The telecom product backlog increased to $20.2 million at December 31, 2000, versus $9.8 million at September 30, 2000. The sales backlog is composed of $2.1 million for collimator products, $15.6 million for isolator products, and $2.5 million for active telecom components. The telecom segment incurred an operating loss of $1.6 million for the second quarter of fiscal 2001 as compared to $0.3 million for the comparable period last year. Our internal focus continues to be on the sale and shipment of products and samples of our Gen3 collimators and development of manufacturing capacity at all of our locations. During the second fiscal quarter of 2001, the expansion work at Horizon's was completed at their automated manufacturing facility which is dedicated to large volume isolator production and the development of next-generation optical subassemblies. Based on the results of customers' testing and qualification of our telecom products, we believe higher-volume production orders will continue to develop. We believe that our increased sales and sales orders reflect this positive feedback and customer qualification. TRADITIONAL OPTICS SEGMENT During the second quarter of fiscal 2001, the majority of our approximately $1.9 million of traditional optics segment sales were $1.7 million in finished lens products and $210,000 from laser optic lenses, versus $250,000 for the first quarter of fiscal 2001 and $225,000 for the comparable period last year. The growth was due to the acquisition of Geltech's traditional optics business in September 2000. Geltech's products are used in data storage and by manufacturers of medical equipment. The majority of their sales are due to custom quotations as they have no direct distribution channels. Revenues for the second quarter of fiscal 2000 included approximately $62,500 in license fees. At 12 LIGHTPATH TECHNOLOGIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS December 31, 2000, we had lens product backlog of $2.8 million as compared to $443,000 at September 30, 2000. The traditional optics segment incurred an operating loss of approximately $275,000 for the second quarter of fiscal 2001 as compared to approximately $169,000 for the comparable period last year. CONSOLIDATED OPERATIONS Our consolidated revenues totaled $7.8 million for the second quarter of fiscal 2001, an increase of approximately $7.5 million or 2694% over revenues for the second quarter of fiscal 2000. The increase was primarily attributable from an increase of $3.1 million (42%) from isolator and other related product sales, $3.1 million (41%) from active telecom components and finished lens sales and $1.3 million (17%) from collimator product sales. At December 31, 2000, our consolidated backlog was $23 million consisting of $15.6 million in isolator sales, $2.1 million for collimator sales, $2.5 million in active components and $2.8 for lens sales, as compared to September 30, 2000 and June 30, 2000 sales backlog of $10.2 million and $4.3 million, respectively. Sales revenues from orders will be recognized in future quarters, generally six to twelve months, as the products are shipped. In second quarter of fiscal 2001, consolidated cost of sales was 61% of product sales, an increase from the first quarter of fiscal 2001, when cost of sales was 56% of product sales and the comparable period last year when cost of sales were 49%. The increase was primarily due to lower margins on telecom products. It is anticipated that our telecom products will continue to maintain a cost of sales in the 60% range for fiscal 2001 as we work to expand our manufacturing capabilities and product lines. During the second quarter of fiscal 2001, selling, general and administrative costs increased by $3.3 million from second quarter of fiscal 2000 to $4.3 million, due to $1.6 million of administrative costs incurred by our acquisitions, Horizon and Geltech, and the $1.6 million increase in LightPath personnel in administration and manufacturing support. We incurred several non-cash charges during the second quarter of fiscal 2001 including, $3.7 million in amortization of acquisition's goodwill and intangibles, and $2.8 million in non-cash stock-based compensation charges. Research and development costs increased by approximately $1.6 million to $1.8 million in second quarter of fiscal 2001 versus 2000 of which $615,000 was due to acquisitions. The majority of development work consisted of expenses associated with the Gen3 collimator assembly, LP1600 opto-mechanical switch and the New Jersey facility where development work is on-going to expand the Company's products to the areas of switches, interconnects and cross-connects for the telecommunications industry. Our acquisitions continue their efforts in the area of isolators and next generation optical subassemblies, diffractive gratings, waveguides, lens arrays and sub-assembly technologies. Investment income increased approximately $601,000 in the second quarter of fiscal 2001 due to the increase in interest earned on temporary investments as a result of an increase in cash balances. Interest expense in the second quarter of fiscal 2001 and the comparable period of fiscal 2000 was not significant. Net loss of $8.8 million in the second quarter of fiscal 2001 was an increase of approximately $7.9 million from the second quarter of fiscal 2000. Of this amount, $6.5 million relates to non-cash charges described above. The remaining $1.4 million increase was due primarily to increased cost of sales and operating costs primarily in selling, general and administrative expense and research and development costs. These increased costs were partially offset by the $7.5 million increase in total revenues and the $601,000 increase in interest income during the second quarter of fiscal 2001. Net loss applicable to common shareholders of $8.9 million for the second quarter of fiscal 2001 included an additional charge of $18,551 attributable to the premium on our outstanding preferred stock. Net loss per share of $0.46 in the second quarter of fiscal 2001 was an increase of $0.14 compared to the second quarter of fiscal 2000 net loss per share of $0.32. Net loss applicable to common shareholders for the second quarter of fiscal 2000 of $2.1 million included an additional noncash charge of $1.1 million for an imputed dividend and $46,522 attributable to the premium on the Company's outstanding preferred stock. 13 LIGHTPATH TECHNOLOGIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS SIX MONTHS ENDED DECEMBER 31, 2000 COMPARED WITH THE SIX MONTHS ENDED DECEMBER 31, 1999 TELECOM SEGMENT During the six months ended December 31, 2000 our optoelectronics and fiber telecommunications segment was impacted by: * continued record telecom sales of $8.6 million and increased telecom sales backlog at December 31, 2000 of approximately $20.2 million. The completion of the expansion of the Horizon automated manufacturing facility which is dedicated to large volume isolator production and the development of next-generation optical subassemblies contributed to the overall sales growth as well as the inclusion of Geltech sales; * the September 20, 2000 expansion of our telecom products to include active components through the acquisition of privately held Geltech. We began acquisition talks with Geltech, due to our interest in their precision molded aspherical optics used in the active telecommunication components markets. The acquisition purchase price was $27.5 million which was paid through the issuance of 822,737 shares of Class A common stock plus we incurred approximately $1 million in acquisition costs for an aggregate purchase price of approximately $28.5 million; * the Company's investment in LightChip, Inc. of $7.2 million (August 2000 private placement significant investors included Berkeley International, Morgenthaler, J.P. Morgan Capital, AT&T Ventures and LightPath); and * the August 2000 introduction of the LP1600 opto-mechanical switch at the National Fiber Optics Engineers Conference is a continuation of our strategic plan to bring additional component products into the telecom sector. The switch employees a patented retro-reflecting mirror design in conjunction with our Gen3 collimator which has the lowest documented insertion loss reported to date in these devices. During the first six months of fiscal 2001 telecom product sales increased to approximately $8.6 million versus $84,927 for the comparable period last year. The telecom segment results include $2.1 million of collimator product sales, isolator sales of $4.8 million and $1.7 million of active telecom product sales. The telecom product backlog increased to $20.2 million at December 31, 2000, versus $9.8 million at September 30, 2000. The backlog is composed of $2.1 million for collimator products, $15.6 million for isolator products, and $2.5 million for active telecom components. Sales to the Microelectronics division of Lucent Technologies Inc.'s ("Lucent") represent 65% of the current sales open orders and represent 40% of the telecom sales for the first six months of fiscal 2001. Lucent has announced that they plan to spin the Microelectronics division into a separate company named Agere Systems, Inc. ("Agere") in February 2001. Horizon, Lucent and Agere have prepared for these changes and we anticipate an organized transition will occur. The telecom segment incurred an operating loss of $3.4 million for the first six months of fiscal 2001 as compared to $0.6 million for the comparable period last year. GELTECH ACQUISITION On August 9, 2000, the Company entered into a definitive agreement to acquire Geltech Inc., a Delaware corporation, for an aggregate purchase price of approximately $28.5 million. Geltech is a manufacturer of precision molded aspherical optics used in the active telecommunication components markets. On the closing date September 20, 2000, LightPath acquired all of the outstanding shares of Geltech in exchange for 822,737 shares of Class A common stock. The acquisition has been accounted for using the purchase method of accounting and, accordingly, the results of operations of Geltech have been included in the 14 LIGHTPATH TECHNOLOGIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Company's consolidated financial statements from September 20, 2000. In the first quarter of fiscal 2000, the Company recorded an immediate non-recurring charge of $9.1 million, due to acquired in-process research and development. The value assigned to in-process R&D was determined based on estimates of the resulting net cash flows from diffractive gratings, waveguides, lens arrays and sub-assembly technologies and the discounting of such cash flows to present value. These programs were in various stages of completion ranging from 30% to 50% of completion, with estimated completion dates through December 2001. This in-process research will have no alternative future uses if the products are not feasible. Revenues from in-process products are estimated primarily beginning in fiscal 2002, with projected research and development costs-to-complete of approximately $2.25 million. In projecting net cash flows resulting from diffractive gratings, waveguides, lens arrays and sub-assembly technologies, management estimated revenues, cost of sales, R&D expenses, selling, general and administrative (SG&A) expenses and income taxes for those projects. These estimates were based on the following assumptions: * Estimated revenues projected a compound annual growth rate over six years of approximately 132%. Projections of revenue growth for the various products in development were based on management's estimates of market size and growth supported by market data and by the nature and expected timing of the development of the products by LightPath and its competitors. * The estimated cost of sales as a percentage of revenue, initially at 51% increasing to 60%, was consistent with the historical rates for Geltech's business as well as its business plan analysis. * Estimated SG&A costs were expected to decrease as a percentage of sales, from 21% initially to approximately 13% in later years. * The estimated R&D costs were expected to remain approximately 10% of sales as most R&D efforts are in a development or maintenance phase. * A 38% effective tax rate was estimated. The projected net cash flows for the in-process projects were discounted using a range of 30% to 65% weighted-average cost of capital (WACC) based on consideration of the perceived risk of each project considering estimated completion percentage, technology advances, market acceptance and future projected financial expectations. The calculation produces the average required rate of return of an investment in an operating enterprise. The WACC selected was based upon venture capital rates of return as required for investment in companies during their early stages of development and reflective of the risk associated with corresponding development/operating challenges. A WACC range of 25% to 30% was used to determine the value of the return of the developed technology, the customer list and other intangibles acquired as part of the purchase of Geltech. TRADITIONAL OPTICS SEGMENT During the first six months of fiscal 2001, the majority of our approximately $2.2 million traditional optics segment sales were from Geltech's lens sales and existing customers for laser optic lenses. Traditional optics sales in the first six months of fiscal 2000 were $462,000. The growth was due to the acquisition of Geltech's traditional optics business in September 2000. Geltech's products are used in data storage and by manufacturers of medical equipment. The majority of their sales are due to custom quotations as they have no direct distribution channels. Revenues for the comparable period of fiscal 2000 included approximately $167,000 in license fees and government funded subcontracts. The traditional optics segment incurred an operating loss of approximately $42,000 for the first six months of fiscal 2001 as compared to approximately $196,000 for the comparable period last year. 15 LIGHTPATH TECHNOLOGIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Joining with the German optical products manufacturer Rodenstock Prazisionsoptik GmbH ("Rodenstock"), we are proceeding with the marketing program for the development, production and joint-distribution of GRADIUM based optical products in Europe. Rodenstock sold their precision optics division to Linos AG, a pioneer in the field of photonics, in June 2000. We believe our agreement and relationships will continue to grow under the Linos AG/Rodenstock alliance. We believe the relationship with Linos AG/Rodenstock may create new and sustain existing markets for GRADIUM in Europe primarily in the area of imaging systems. Our remaining distributors continue to work with existing markets for GRADIUM in their respective countries primarily in the area of the YAG laser market. At December 31, 2000, we had a lens product backlog of $2.8 million as compared to $443,000 at September 30, 2000. CONSOLIDATED OPERATIONS Our consolidated revenues totaled $10.8 million for the first six months of fiscal 2001, an increase of approximately $10.3 million or 1879% over the first six months of fiscal 2000. The increase was primarily attributable from an increase of $4.8 million (47%) in isolator and other sales, $3.5 million (34%) from active telecom components and finished lenses and $2 million (19%) primarily from collimator products. At December 31, 2000, our consolidated backlog was $23 million consisting of $15.6 million in isolator sales, $2.1 million for collimator sales, $2.5 million in active components and $2.8 for lens sales, as compared to September 30, 2000 sales backlog of $10.2 million. Sales revenues from orders will be recognized in future quarters, generally six to twelve months, as the products are shipped. During the first six months of fiscal 2001, consolidated cost of sales was 59% of product sales an increase from the comparable period of fiscal 2000, when cost of sales was 50% of product sales. The increase was primarily due to lower margins on telecom products. It is anticipated that our telecom products will continue to maintain a cost of sales in the 60% range for fiscal 2001 as we work to expand our manufacturing capabilities and product lines. During the first six months of fiscal 2001, selling, general and administrative costs increased by $6 million from the comparable period of fiscal 2000 to $7.8 million, due to $2.3 million of administrative costs incurred by our acquisitions, Horizon and Geltech, and $3.1 million from increases in LightPath personnel in administration and manufacturing support. We incurred several non-cash charges during the first six months of fiscal 2001, including Geltech's $9.1 million non-recurring in-process research and development charge, $6.2 million in amortization of acquisition's goodwill and intangibles, and $5.5 million in non-cash stock-based compensation charges. Research and development costs increased by approximately $2.8 million to $3.1 million in the first six months of fiscal 2001 versus the comparable period of fiscal 2000 of which $1 million was due to acquisitions. The majority of development work consisted of expenses associated with the Gen3 collimator assembly, LP1600 opto-mechanical switch and the New Jersey facility where development work is on-going to expand the Company's products to the areas of switches, interconnects and cross-connects for the telecommunications industry. Our acquisitions continue their efforts in the area of isolators and next generation optical subassemblies, diffractive gratings, waveguides, lens arrays and sub-assembly technologies. Investment income increased approximately $1.4 million in the first six months of fiscal 2001 due to the increase in interest earned on temporary investments as a result of an increase in cash balances. Interest expense was not significant in 2001. In July 1999, we issued $1 million aggregate principal amount of 6% convertible debentures and paid approximately $10,000 of interest expense. We recognized an interest charge of $381,869 in the first quarter of fiscal year 2000 for the "beneficial conversion feature" associated with the Debentures and $43,926 of the remaining debt discount was amortized from the issuance date through September 24, 1999 when all of the Debentures were converted and related warrants were exercised into approximately one million shares of Class A Common Stock. 16 LIGHTPATH TECHNOLOGIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Net loss of $25.8 million in the first six months of fiscal 2001 was an increase of approximately $23.8 million from the comparable period of fiscal 2000. Of this amount, $20.8 million relates to non-cash charges described above. The remaining $3 million increase was due primarily to increased cost of sales and operating costs, primarily in selling, general and administrative expense and a $2.8 million increase in research and development costs. These increased costs were partially offset by the $10.3 million increase in total revenues, $1.4 million increase in interest income and the $387,000 reduction of interest expense during the first six months of fiscal 2001. Net loss applicable to common shareholders of $25.8 million for the first six months of fiscal 2001 included an additional charge of $45,464 attributable to the premium on our outstanding preferred stock. Net loss per share of $1.38 in the first six months of fiscal 2001 was an increase of $0.85 compared to the comparable period of fiscal 2000 net loss per share of $0.53. Net loss applicable to common shareholders of $3.2 million in the first six months of fiscal 2000 included an additional charge of $1.1 million for the imputed dividend and $54,680 attributable to the premium on the Company's outstanding preferred stock. FINANCIAL RESOURCES AND LIQUIDITY We financed our initial operations through private placements of equity and debt until February 1996 when our initial public offering of units of common stock and Class A and B Warrants generated net proceeds of approximately $7.2 million. From June 1997 through November 1999, we completed four preferred stock and one convertible debt private placements which generated total net proceeds of approximately $12 million. During fiscal 2000, we received net proceeds of approximately $66 million from the exercise of stock options and warrants issued at the initial public offering or in connection with previous private placements. During the first six months of fiscal 2001, we have received net proceeds of approximately $1.1 million from the exercise of stock options and warrants. Cash used in operations for the six months ended December 31, 2000, was approximately $9.6 million, an increase of approximately $8.3 million from the same period of fiscal 2000. Working capital needs for growth in accounts receivable due to increased sales and increased raw materials maintained in inventory account for $4.9 million of the increase, and the balance is due to increased administrative costs due to our acquisitions and increases in staff. We expect to continue to incur net losses until such time, if ever, as we obtain market acceptance for our products at sale prices and volumes which provide adequate gross revenues to offset our operating costs. During six months ended December 31, 2000, we expended approximately $4 million for capital equipment and patent protection. The majority of the capital expenditures during the year were related to the development of our clean rooms and equipment used to expand our manufacturing facilities. We have outstanding budget commitments for fiscal 2001 to expend an additional $6 million for capital equipment and patent protection, of which $4.5 million will be used to fund expansion of Geltech's manufacturing facilities over the next 18 months. The remaining fiscal 2001 projected capital expenditures are for research and development equipment and construction of additional collimator manufacturing and testing stations. In August 2000, we purchased $7.2 million of LightChip, Inc. preferred stock as part of a private placement in which LightChip, Inc. issued $60 million of convertible preferred stock to outside investors including LightPath. In September 2000, we acquired Geltech, a Delaware corporation, for an aggregate purchase price (including expenses) of approximately $28.5 million. We acquired all of the outstanding shares of Geltech for 822,737 shares of Class A common stock. Expenses of approximately $1 million incurred for the acquisition were provided from working capital. Since the acquisition, approximately $800,000 of acquired debt has been repaid from working capital. INFLATION; SEASONALITY The Company has not been significantly impacted by inflation in 2001 due to the nature of its product components. The Company does not believe that seasonal factors will have a significant impact on its business. RECENT ACCOUNTING PRONOUNCEMENTS In December 1999, the Securities and Exchange Commission (SEC) issued Staff Accounting Bulletin (SAB) No. 101, Revenue Recognition in Financial Statements. This bulletin summarizes certain of the staff's views in applying generally accepted accounting principles to revenue recognition in financial statements. In June 2000, the SEC issued SAB No. 101B that delayed the implementation date of SAB No. 101 until the fourth fiscal quarter of fiscal years beginning after December 15, 1999, although early adoption is allowed. We do not expect our adoption of the provisions of this statement effective April 1, 2001, to have a material effect on our results of operations or financial position. 17 LIGHTPATH TECHNOLOGIES, INC. PART II ITEM 1. LEGAL PROCEEDINGS On May 2, 2000, the Company commenced a class action lawsuit in the Chancery Court of Delaware, New Castle County. The action seeks a declaratory judgment with respect to the Company's right to redeem the Class E Common Stock on December 31, 2000 for $.0001 per share, the right of the holders of Class E Common Stock to vote at the Annual Meeting to be held on October 6, 2000, and for certification of the holders of Class E Common Stock as a class and the named defendants as its representatives. The named defendants are Donald E. Lawson, President, Chief Executive Officer and a Director of the Company, who owns an aggregate of 25,000 shares of Class E Common Stock, Louis G. Leeburg, a Director of the Company, who owns an aggregate of 7,272 shares of Class E Common Stock, and William Leeburg, who owns or controls an aggregate of 21,816 shares of Class E Common Stock. The Company entered into a proposed settlement of this lawsuit whereby the holders of Class E Common Stock could elect to receive $.40 for each share of Class E Common Stock or a two year option to purchase one Class A Common Stock for each 100 shares of Class E Common Stock they hold. The option would be priced at the fair market value of the Class A Common Stock on the settlement date. The Company estimates that if all of the Class E Common Stock were exchanged for options to purchase Class A Common Stock, approximately 40,221 shares of Class A Common Stock would be issued. If all of the Class E Common Stock were exchanged for cash, approximately $1.6 million would be expended. On January 8, 2001, the Delaware Chancery Court held a hearing on the proposed settlement. The settlement proposal was made to include all holders of Class E Common Stock holders. On February 2, 2001, the Delaware Chancery Court issued a letter in which it indicated that holders of Class E Common Stock must be provided an opportunity to request exclusion from the settlement class. In light of the Chancery Court's letter, the Company is evaluating the proposed settlement offer and exploring various other strategies for resolving the Delaware lawsuit. Due to the uncertainty regarding the proposed settlement offer, the different exchange methods and the coverage of insurance for such claims, the Company has not been able to determine that it is probable that the settlement offer above will occur nor the likely amounts to be accrued for any possible settlement costs. On or about June 9, 2000, a small group of holders of Class E Common Stock commenced an action in a state court in Texas (the "Texas Action"). In essence, the Texas Action makes various allegations regarding the circumstances surrounding the issuance of the Class E Common Stock and seeks damages based upon those allegations. The Company believes the allegations underlying the Texas Action have no basis in fact and that this lawsuit is without merit. The Company has retained counsel and intends to vigorously defend against these claims. On November 15, 2000, the Company filed a complaint against Carmichael & Company LLC, in the State of New Mexico, for violation of its agreement with the Company as financial advisors and seeking to terminate the agreement. On or about November 15, 2000, Carmichael & Company LLC filed a complaint against the Company in the State of New York, for breach of contract and claiming approximately $5 million in damages. The Company believes the allegations underlying the New York claims have no basis in fact and that this lawsuit is without merit. The Company has retained counsel and intends to vigorously defend against these claims. LightPath is subject to various other claims and lawsuits in the ordinary course of its business, none of which are considered material to the Company's financial condition and results of operations. Except as set forth above, there have been no material developments in any legal actions reported in the Company's Form 10-KSB for the year ended June 30, 2000. ITEM 2. CHANGES IN SECURITIES AND USE OF PROCEEDS None 18 ITEM 3. DEFAULTS UPON SENIOR SECURITIES None ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS LightPath Technologies, Inc. conducted its 2000 Annual Meeting of Stockholders on October 6, 2000. Actions concluded at the meeting through submission of matters to a vote by stockholders was conducted by proxy and included the following: 1. Election of a Class II Director to hold office until the Annual Meeting of Stockholders in 2003. The election of James Adler Jr. as Class II Director of the Company was approved by a vote of Class A shareholders of 17,648,553 FOR and 397,197 WITHHOLD AUTHORITY and by a vote of Class E shareholders of 2,158,370 FOR and 279,441 WITHHOLD AUTHORITY. The terms of the Company's Class III Directors, Donald Lawson and Louis Leeburg and of its Class I Directors, Robert Ripp and Leslie Danziger continued after the date of the Annual Meeting. 2. Ratification of the selection of KPMG LLP as independent accountants for the Company for the fiscal year ending June 30, 2001 was approved by a vote of Class A shareholders 17,976,405 FOR; 54,674 AGAINST and 15,343 ABSTENTIONS and by a vote of Class E shareholders of 2,190,308 FOR; 297,009 AGAINST and 0 ABSTENTIONS. 3. Amendment of the 1992 Omnibus Incentive Plan to increase the number of shares of Class A Common Stock available for issuance thereunder by 1,450,000 shares was approved by the stockholders by a vote of Class A shareholders 7,160,364 FOR; 1,453,420 AGAINST and 63,936 ABSTENTIONS and by a vote of Class E shareholders of 2,060,547 FOR; 367,228 AGAINST and 51,169 ABSTENTIONS. 4. Amendment of the Amended and Restated Directors Stock Option Plan to increase the number of shares of Class A Common Stock available for issuance thereunder by 100,000 shares was approved by a vote of Class A shareholders 7,345,660 FOR; 1,277,840 AGAINST and 54,592 ABSTENTIONS and by a vote of Class E shareholders of 2,036,288 FOR; 348,287 AGAINST and 52,204 ABSTENTIONS. ITEM 5. OTHER INFORMATION None ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K a) Exhibits None b) There were no reports on Form 8-K filed under the Securities Exchange Act of 1934 during the quarter ended December 31, 2000. 19 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed in its behalf by the undersigned, thereunto duly authorized. LIGHTPATH TECHNOLOGIES, INC. By: /s/ Donna Bogue February 13, 2001 ------------------------------------------ Donna Bogue Date Chief Financial Officer 20